| DAA1488 |
ubiquitin associated domain containing 1 |
Ubac1 |
3.0% Decrease Gene Expression Level |
kidney |
Mouse |
|
| DAA2090 |
ubiquitination factor E4B (UFD2 homolog, yeast) decreases with age |
UBE4B |
43.8% Decrease Gene Expression Level |
ovary |
Human |
|
| DAA2080 |
ubiquitin-conjugating enzyme E2D 2 (UBC4/5 homolog, yeast) decreases with age |
UBE2D2 |
48.2% Decrease Gene Expression Level |
ovary |
Human |
|
| DAA491 |
ubiquitin-conjugating enzyme E2E 2 (UBC4/5 homolog, yeast) |
UBE2E2 |
5.0% Increase Gene Expression Level |
skeletal muscle |
Human |
|
| DAA1889 |
ubiquitin-conjugating enzyme E2G 1 (UBC7 homolog, C. elegans) |
Ube2g1 |
2.0% Decrease Gene Expression Level |
skeletal muscle |
Mouse |
|
| DAA1836 |
ubiquitin-conjugating enzyme E2L 3 |
Ube2l3 |
2.0% Decrease Gene Expression Level |
muscle |
Mouse |
|
| DAA1274 |
ubiquitin specific peptidase 37 |
Usp37 |
7.0% Increase Gene Expression Level |
brain |
Mouse |
|
| DAA2115 |
ubiquitin specific peptidase 42 increases with age |
USP42 |
60.0% Increase Gene Expression Level |
ovary |
Human |
|
| DAA375 |
ubiquitin specific peptidase 6 (Tre-2 oncogene) |
USP6 |
5.0% Increase Gene Expression Level |
skeletal muscle |
Human |
|
| DAA1106 |
UDP-Gal:betaGal Beta 1,3-galactosyltransferase Polypeptide 6 |
B3GALT6 |
Increase DNA Methylation |
frontal lobe |
Human |
|
| DAA1107 |
UDP-Gal:betaGal Beta 1,3-galactosyltransferase Polypeptide 6 |
B3GALT6 |
Increase DNA Methylation |
pons |
Human |
|
| DAA1105 |
UDP-Gal:betaGal Beta 1,3-galactosyltransferase Polypeptide 6 |
B3GALT6 |
Increase DNA Methylation |
cerebellum |
Human |
|
| DAA1108 |
UDP-Gal:betaGal Beta 1,3-galactosyltransferase Polypeptide 6 |
B3GALT6 |
Increase DNA Methylation |
temporal lobe |
Human |
|
| DAA1324 |
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1 |
B3galt1 |
36.0% Increase Gene Expression Level |
hematological system |
Mouse |
|
| DAA2106 |
uridine-cytidine kinase 1-like 1 increases with age |
UCKL1 |
86.0% Increase Gene Expression Level |
ovary |
Human |
|
| DAA384 |
vacuolar protein sorting 13 homolog C (S. cerevisiae) |
VPS13C |
3.0% Increase Gene Expression Level |
skeletal muscle |
Human |
|
| DAA2104 |
vacuolar protein sorting 13 homolog C (S. cerevisiae) decreases with age |
VPS13C |
58.7% Decrease Gene Expression Level |
ovary |
Human |
|
| DAA423 |
vascular endothelial growth factor B |
VEGFB |
6.0% Decrease Gene Expression Level |
skeletal muscle |
Human |
|
| DAA1372 |
vasorin |
Vasn |
10.0% Decrease Gene Expression Level |
hematological system |
Mouse |
|
| DAA1888 |
VDNA-damage regulated autophagy modulator 2 |
Dram2 |
16.0% Increase Gene Expression Level |
skeletal muscle |
Mouse |
|
| DAA1911 |
v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) |
Erbb3 |
8.0% Increase Gene Expression Level |
Anatomical System |
Mouse |
|
| DAA50 |
versican |
VCAN |
20.0% Increase Gene Expression Level |
brain |
Human |
|
| DAA517 |
very low density lipoprotein receptor |
VLDLR |
4.0% Decrease Gene Expression Level |
skeletal muscle |
Human |
|
| DAA1472 |
vesicle-associated membrane protein 2 |
Vamp2 |
39.0% Decrease Gene Expression Level |
kidney |
Mouse |
|
| DAA245 |
vesicle-associated membrane protein 2 (synaptobrevin 2) |
VAMP2 |
4.0% Decrease Gene Expression Level |
brain |
Human |
|